Hyundai Bioscience Ltd.

Hyundai Bioscience Co., Ltd., a South Korean biotech firm, specializes in drug delivery systems and skin‑health products. Its portfolio includes Vitabrid C12 vitamin‑C skincare, Polytaxel for pancreatic cancer, and CP‑COV03 COVID‑19 therapeutic, underscoring strong R&D pipeline.

Headquarters: South Korea (KOR)

Hyundai Bioscience Ltd. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
048410 Hyundai Bioscience Ltd.
Cap: 599.3B
EQUITY KOE KRW KR7048410005 Active
📈
Home Login